Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism

Journal of Cellular Physiology

Volumn 229, Issue 8, 2014, Pages 1096-1105

  Engelhardt, Sabrina ^a   Al Ahmad, Abraham J ^b   Gassmann, Max ^a   Ogunshola, Omolara O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; BETA CATENIN; CD31 ANTIGEN; CLAUDIN 5; HYPOXIA INDUCIBLE FACTOR 1; LIFICIGUAT; OCCLUDIN; PROTEIN ZO1; VASCULAR ENDOTHELIAL CADHERIN;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN CELL; CELL DISRUPTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOXIA; HYPOXIC CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

ANIMALS; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; TIGHT JUNCTION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899061373     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24544     Document Type: Article

References (51)

1. Abbruscato TJ, Davis TP. 1999. Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. J Pharmacol Exp Ther 289:668-675.
2. Al Ahmad A, Gassmann M, Ogunshola OO. 2009. Maintaining blood-brain barrier integrity: Pericytes perform better than astrocytes during prolonged oxygen deprivation. J Cell Physiol 218:612-622.
3. Al Ahmad A, Gassmann M, Ogunshola OO. 2012. Involvement of oxidative stress in hypoxia-induced blood-brain barrier breakdown. Microvasc Res 84:222-225.
4. Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO. 2011. Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab 31:693-705.
5. Andras IE, Deli MA, Veszelka S, Hayashi K, Hennig B, Toborek M. 2007. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab 27:1431-1443.
6. Baum B, Georgiou M. 2011. Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 192:907-917.
7. Blasig IE, Bellmann C, Cording J, Del Vecchio G, Zwanziger D, Huber O, Haseloff RF. 2011. Occludin protein family: Oxidative stress and reducing conditions. Antioxid Redox Signal 15:1195-1219.
8. Brown RC, Davis TP. 2005. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun 327:1114-1123.
9. Chen C, Ostrowski RP, Zhou C, Tang J, Zhang JH. 2010. Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia. J Neurosci Res 88:2046-2055.
10. Daneman R. 2012. The blood-brain barrier in health and disease. Ann Neurol 72:648-672.
11. Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H, Huang Q, Zhang F, Bao H, Jia L, Wu X, Zhu X, Zhang X, Zhang Z, Chen Z. 2010. The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell 18:52-63.
12. Fandrey J, Gassmann M. 2009. Oxygen sensing and the activation of the hypoxia inducible factor 1 (HIF-1)-invited article. Adv Exp Med Biol 648:197-206.
13. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W, Karliczek GF. 1999. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276:C812-C820.
14. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. 2002. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63:70-80.
15. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. 2003. Tight junction proteins. Prog Biophys Mol Biol 81:1-44.
16. Harhaj NS, Antonetti DA. 2004. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206-1237.
17. Harten SK, Ashcroft M, Maxwell PH. 2010. Prolyl hydroxylase domain inhibitors: A route to HIF activation and neuroprotection. Antioxid Redox Signal 12:459-480.
18. Hawkins BT, Davis TP. 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185.
19. Johnson PH, Frank D, Costantino HR. 2008. Discovery of tight junction modulators: Significance for drug development and delivery. Drug Discov Today 13:261-267.
20. Kale G, Naren AP, Sheth P, Rao RK. 2003. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 302:324-329.
21. Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, Fujimori T, Nabeshima Y, Noda T, Tsukita S. 2008. Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 19:2465-2475.
22. Kimura K, Teranishi S, Kawamoto K, Nishida T. 2010. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor. Exp Eye Res 90:337-343.
23. Kimura K, Teranishi S, Kawamoto K, Nishida T. 2011. Protective effect of dexamethasone against hypoxia-induced disruption of barrier function in human corneal epithelial cells. Exp Eye Res 92:388-393.
24. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E. 2007. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 170:1389-1397.
25. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. 2008. Structure and function of claudins. Biochim Biophys Acta 1778:631-645.
26. Liu J, Jin X, Liu KJ, Liu W. 2012. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci 32:3044-3057.
27. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, Davis TP. 2010. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30:1625-1636.
28. Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. 2012. Tight junctions at the blood brain barrier: Physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9:23.
29. Luo J, Martinez J, Yin X, Sanchez A, Tripathy D, Grammas P. 2012. Hypoxia induces angiogenic factors in brain microvascular endothelial cells. Microvasc Res 83:138-145.
30. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P. 2003. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375.
31. McCaffrey G, Willis CL, Staatz WD, Nametz N, Quigley CA, Hom S, Lochhead JJ, Davis TP. 2009. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 110:58-71.
32. Minchenko A, Bauer T, Salceda S, Caro J. 1994. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374-379.
33. Miyata T, Takizawa S, van Ypersele de Strihou C. 2011. Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: Novel therapeutic targets. Am J Physiol Cell Physiol 300:C226-C231.
34. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660.
35. Ogunshola OO, Al-Ahmad A. 2012. HIF-1 at the blood-brain barrier: A mediator of permeability? High Alt Med Biol 13:153-161.
36. Roll FJ, Madri JA, Albert J, Furthmayr H. 1980. Codistribution of collagen types IV and AB2 in basement membranes and mesangium of the kidney. an immunoferritin study of ultrathin frozen sections. J Cell Biol 85:597-616.
37. Rosenberg GA. 2012. Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 32:1139-1151.
38. Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, Bourre JM, Strosberg AD, Couraud PO. 1994. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 159:101-113.
39. Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH. 2006. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281:23482-23491.
40. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E. 2008. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923-934.
41. Takenaga Y, Takagi N, Murotomi K, Tanonaka K, Takeo S. 2009. Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J Cereb Blood Flow Metab 29:1099-1108.
42. Walsh TG, Murphy RP, Fitzpatrick P, Rochfort KD, Guinan AF, Murphy A, Cummins PM. 2011. Stabilization of brain microvascular endothelial barrier function by shear stress involves VE-cadherin signaling leading to modulation of pTyr-occludin levels. J Cell Physiol 226:3053-3063.
43. Wenger RH, Stiehl DP, Camenisch G. 2005. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005:re12.
44. Witt KA, Mark KS, Hom S, Davis TP. 2003. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 285:H2820-H2831.
45. Witt KA, Mark KS, Sandoval KE, Davis TP. 2008. Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res 75:91-96.
46. Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul Pharmacol 38:323-337.
47. Xia Y, Choi HK, Lee K. 2012. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem 49:24-40.
48. Yan J, Zhang Z, Shi H. 2012. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci 69:115-128.
49. Yan J, Zhou B, Taheri S, Shi H. 2011. Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke. PLoS ONE 6:e27798.
50. Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM. 2007. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 72:440-449.
51. Zehendner CM, Librizzi L, de Curtis M, Kuhlmann CR, Luhmann HJ. 2011. Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS ONE 6:e16760.